ArticleToxicologic pathology2016

Scientific and Regulatory Policy Committee Points to Consider Review: Inclusion of Reproductive and Pathology End Points for Assessment of Reproductive and Developmental Toxicity in Pharmaceutical Drug Development.

Wendy G Halpern et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.